Task: Answer the multiple-choice question.
Question: Which compound exhibits a 15.093% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CSc1ncc(CNc2cc([N+](=O)[O-])ccc2C)c(N)n1
b C=CCOc1ccc(/C=C2/C(=O)ON=C2C)cc1OC
c CCOC(=O)c1c(C)c(C(=O)NCCN2CCOCC2)c(C)n1C
Answer: c. CCOC(=O)c1c(C)c(C(=O)NCCN2CCOCC2)c(C)n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1c(C)c(C(=O)NCCN2CCOCC2)c(C)n1C
CCOC(=O)c1c(C)c(C(=O)NCCN2CCOCC2)c(C)n1C
ethyl 1,3,5-trimethyl-4-(2-morpholin-4-ylethylcarbamoyl)pyrrole-2-carboxylate